Cyclosporine a preparations and their vehicles induce contraction of the guinea pig gallbladder in vitro: The role of cyclooxygenase metabolites

Pharmacology

Volumn 58, Issue 6, 1999, Pages 309-318

  Yasar, U ^a   Erdem, S R ^a   Tuncer, Meral ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cyclosporine; Gallbladder; Prostanoids; Thromboxane A2

Indexed keywords

ACETYLCHOLINE; CREMOPHOR; CYCLOSPORIN A; DRUG VEHICLE; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; MEPACRINE; PEGLICOL 5 OLEATE; RIDOGREL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GALLBLADDER CONTRACTION; GUINEA PIG; NONHUMAN; ODDI SPHINCTER; PRIORITY JOURNAL;

ACETYLCHOLINE; ADMINISTRATION, ORAL; ANIMALS; CYCLOOXYGENASE INHIBITORS; CYCLOSPORINE; ENZYME INHIBITORS; FEMALE; GALLBLADDER; GUINEA PIGS; IMMUNOSUPPRESSIVE AGENTS; INDOMETHACIN; MALE; MUSCLE CONTRACTION; PENTANOIC ACIDS; PYRIDINES; QUINACRINE; SPHINCTER OF ODDI; VASODILATOR AGENTS; VEHICLES;

EID: 0033005868     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028296     Document Type: Article

References (35)

1. Bennett WM, Pulliam JP: Cyclosporine nephrotoxicity. Ann Intern Med 1983;99:851-854.
2. Bellet M, Cabrol C, Sassano P, Carvol P, Menard J: Systemic hypertension after cardiac transplantation. Effect of cyclosporine on the reninangiotensin-aldosterone system. Am J Cardiol 1985;56:927-931.
3. Whiting PH, Thompson AW, Simpson JG: Cyclosporine: toxicity, metabolism and drug interactions: Implications from animal studies. Transplant Proc 1985;17:134-144.
4. Ptachinski RJ, Venkataramanan R, Burckart GJ: Clinical pharmacokinetics of cyclosporine. Clin Pharm 1986;11:107-132.
5. Stone BG, Udani M, Sanghvi A, Warthy V, Plocki K, Bedetti CD, Van Thiel DH: Cyclosporine A-induced cholestasis. The mechanism in a rat model. Gastroenterology 1987;93:341-351.
6. Le Thai B, Dumont M, Michel A, Erlinger S, Houssin D: Cholestatic effect of cyclosporine in the rat. An inhibition of bile acid secretion. Transplantation 1988;46:510-512.
7. Chanussot F, Botta-Fridlund D, De La Porte PL, Sbarra V, Portugal H, Pauli AM, Hauton J, Gauthier A, Lafont H: Effects of cyclosporine and corticosteroids on bile secretion in the rat. Transplantation 1992;54: 226-231.
8. Meshkinpour H, Mollot M, Eckerling GB, Bookman L: Bile duct dyskinesia. Clinical and manometric study. Gastroenterology 1984;87: 759-762.
9. Gregg JA, Antal RD: Rhythm abnormalities of the biliary and pancreatic sphincters. Diagnosis by endoscopic manometry. Am J Surg 1984;148:602-606.
10. Torsoli A, Corazziari E, Habib FI, Cicala M: Pressure relationships within the human bile tract. Normal and abnormal physiology. Scand J Gastroenterol 1990;25(suppl 175): 52-57.
11. 2 release from vascular smooth muscle cells. Biochem Biophys Res Commun 1987;147:542-549.
12. 2 formation in isolated glomeruli and papilla of rat kidneys. Clin Nephrol 1986;25(suppl 1):78-82.
13. 2 in rats caused by cyclosporine. Transplantation 1985;40:214-216.
14. Foegh ML, Lim KL, Alijani MR, Helfrich GB, Ramwell P: Thromboxane and inflammatory cell infiltration of the allograft of renal transplant patients. Transplant Proc 1987;19:3633-3636.
15. Gocer F, Yaris E, Tuncer M: The action of amyl nitrite and isosorbide dinitrate on the contractility of sphincter of Oddi of guinea-pigs. Gen Pharmacol 1994;25:995-999.
16. Arias IM: Cyclosporin, the biology of the bile canaliculus, and cholestasis. Gastroenterology 1993;104: 1558-1560.
17. Bohme M, Muller M, Leier I, Jedlitschky G, Keppler D: Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology 1994;107:255-265.
18. Funch-Jensen P: Biliary motility. Scand J Gastroenterol 1987;22 (suppl 128).70-77.
19. Funch-Jensen P: Sphincter of Oddi motility. Acta Chir Scand Suppl 1990;553:1-35.
20. Amorena C, Castro A, Müller A, Villamil MF: Direct vascular effects in the rat of the vehicles used for the intravenous and oral administration of cyclosporin A. Clin Sci 1990;79: 149-154.
21. Yaris E, Tuncer M, Ilhan M: Actions of cyclosporin A preparation and Cremophor-EL in rabbit mesenteric artery and thoracic aorta in vitro. Clin Sci 1992;83:179-182.
22. Yaris E, Tuncer M, Kayaalp SO, Ilhan M: Direct vascular smooth muscle contractile effect of cyclosporin A and its vehicle in rabbit isolated arteries. Arch Int Pharmacodyn Thér 1994;327:166-174.
23. 2. Fed Proc 1987;46:133-138.
24. Finn WF, Hak LJ, Grossman SH: Protective effect of prostacyclin on postischemic acute renal failure in the rat. Kidney Int 1987;32:479-487.
25. Erman A, Chen-Gal B, Rosenfeld J: Cyclosporin treatment alters prostanoid and thromboxane production by rat isolated kidney mitochondria. J Pharm Pharmacol 1990;42:181-185.
26. 2. Transplant Proc 1985;17:1381-1383.
27. Burton GA, Muller B, Schmidtke M: Iloprost preserves endothelial function against cyclosporin A and sensitises microvessels towards endothelium-dependent and -independent vasodilatation. Agents Actions Suppl 1992;37:340-345.
28. Perico N, Rossini M, Imberti O, Malachini B, Cornejo RP, Gasrari F, Bertani T, Remuzzi G: Thromboxane receptor blockade attenuates chronic cyclosporine nephrotoxicity and improves survival in rats with renal isograft. J Am Soc Nephrol 1992;2:1398-1404.
29. Weir MR, Klassen DK, Burdick JF: A pilot study to assess the ability of an orally available selective thromboxane synthase inhibitor to improve renal function in cyclosporine-treated renal transplant recipients. J Am Soc Nephrol 1992;2: 1285-1290.
30. Smith SR, Creech EA, Schaffer AV, Martin LL, Rakhit A, Douglas FL, Klotman PE, Coffman TM: Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicity. Kidney Int 1992;41:199-205.
31. 2α on rhythmic contractions of sphincter of Oddi. Gen Pharmacol 1995;26: 1397-1401.
32. Wyatt AP: The relationship of the sphincter of Oddi to the stomach, duodenum and gallbladder. J Physiol 1967;193:225-243.
33. Doty JE, Pitt HA, Kuckenbecker SL, DenBesten L: Effect of gallbladder filling and cholecystokinin on the prairie dog sphincter of Oddi. Surg Forum 1981;32:148-150.
34. Ptachcinski RJ, Burckart GJ, Venkataramanan R: Cyclosporine. Drug Intell Clin Pharm 1985;19:90-100.
35. Griffith BP, Hardesty RL, Trento A, Lee A, Bahnson HT: Targeted blood levels of cyclosporine for cardiac transplantation. J Thorac Cardiovasc Surg 1984;88:952-957.